Risk factors for relapse after discontinuation of tenofovir or entecavir in hepatitis B e Antigen-Negative Patients
Article in Hepatology Forum (January 2024)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial
Article in The American Journal of Gastroenterology (January 2023)
Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis
Article in Frontiers in Public Health (November 2022)